Analyst Ratings for Stoke Therapeutics (STOK)
STOK Rating Summary
STOK Price Target Summary
- Highest: $60.00 (Guggenheim)
- Lowest: $35.00 (Chardan)
- Average: $44.40
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$44.40 (+51.3%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 84%
Rating Score: 8.2 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/21/2026 | JPMorgan | Jessica Fye | New Coverage | Overweight (N/A) |
40.00 (N/A) |
33.03 (29.34) |
-11.17% | Details |
| 7/13/2026 | Goldman Sachs » Updated 9/10/2026 |
Kevin Strang | New Coverage | Buy (N/A) |
44.00 (N/A) |
31.38 (29.34) |
-6.5% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
